The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2022 | The importance of early treatment in MGRS & the role of the MDT
Artur Jurczyszyn, MD, PhD, Jagiellonian University Medical College, Kraków, Poland, comments on the importance of early treatment of patients with monoclonal gammopathy of renal significance (MGRS) with autologous transplantation, highlighting the role of the multidisciplinary team (MDT) in the management of these patients. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
